注册以创建品种、
财经事件和所关注作者内容的提醒
免费注册 已有账户? 登录
Aeterna Zentaris Inc是一家从事商业化开发治疗和诊断测试的专业生物制药公司。该公司的主导产品Macrilen (macimorelin)是一种用于诊断成人生长激素缺乏症(AGHD)患者的口服试验。Macrilen (macimorelin)是一种口服可用的拟肽ghrelin受体激动剂,通过与ghrelin受体(GHSR-1a)结合来刺激生长激素的分泌,并在内分泌学和肿瘤学适应症中都有应用。该公司还利用macimorelin的临床和令人信服的安全性来开发用于诊断儿童期生长激素缺乏症 (CGHD) 的产品。它还在开发针对SARS-CoV-2(导致COVID-19的病毒)和沙眼衣原体的口服预防性细菌疫苗。该公司专注于马西莫林在亚洲和世界其他地区的商业化。
名称 | 年龄 | 任期 | 标题 |
---|---|---|---|
Dennis Turpin | - | 1999 | Independent Director |
Ulf R. Rapp | - | - | Member of the Scientific Advisory Board |
Marcel Verheij | - | - | Member of the Scientific Advisory Board |
Gerald Batist | - | - | Member of the Scientific Advisory Board |
Gilles R. Gagnon | 70 | 2007 | Independent Director |
Hartmut Michel | - | - | Member of the Scientific Advisory Board |
Alan H. DeCherney | - | - | Member of the Scientific Advisory Board |
Frans M. J. Debruyne | - | - | Member of the Scientific Advisory Board |
Peter G. Edwards | 63 | 2020 | Independent Director |
Klaus Paulini | - | 2019 | President, CEO & Executive Director |
Daniel Douglas Von Hoff | 76 | 2005 | Member of the Scientific Advisory Board |
Klaus H. R. Diedrich | - | - | Member of the Scientific Advisory Board |
René Frydman | - | - | Member of the Scientific Advisory Board |
Carolyn S. Egbert | - | 2012 | Independent Chair of the Board |
确定屏蔽%USER_NAME%?
如果屏蔽,您和%USER_NAME%都无法看到相互在Investing.com上发布的信息。
%USER_NAME%已成功添加至屏蔽列表
由于您刚刚取消屏蔽此人,因此必须等待48小时才能重新屏蔽。
您举报该评论的原因为:
谢谢您!
您的举报将会被发送到管理员进行审核